Quick Listen: Scrip's Five Must-Know Things

 
• By Ian Haydock

In this week's podcast edition of Five Must-Know Things: Pfizer’s cost improvement and COVID outlook; Roche CEO outlines M&A criteria; Organon maintains women’s health focus; will Indian pharma families sell their stakes; and a look at new therapies in the pipeline for multiple myeloma.

Scrip Five Must Know Things
weekly audio roundup of selected content from Scrip's global team

More from Business

More from Scrip